Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study

The Journal of Urology ◽

10.1016/j.juro.2008.11.012 ◽

2009 ◽

Vol 181 (3) ◽

pp. 1098-1103 ◽

Author(s):

Carla Schwenke ◽

Burkhard Ubrig ◽

Petra Thürmann ◽

Christian Eggersmann ◽

Stephan Roth

Keyword(s):

Prostate Cancer ◽

Pilot Study ◽

Phase Ii ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Faculty Opinions recommendation of Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1165617.628635 ◽

2009 ◽

Author(s):

Yoshihiko Hirao ◽

Kiyohide Fujimoto

Keyword(s):

Prostate Cancer ◽

Pilot Study ◽

Phase Ii ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81827-9 ◽

1999 ◽

Vol 35 ◽

pp. S349 ◽

Author(s):

A. Einstein ◽

R. Lush ◽

R. Rago ◽

G. Bubley ◽

W.D. Henner ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase II trial of anti-idiotypic p53 peptides (Pentrys) plus granulocyte-macrophage colony-stimulating factor in patients with hormone-refractory prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2007.00101.x ◽

2007 ◽

Vol 3 (3) ◽

pp. 148-155

Author(s):

Ian D DAVIS ◽

Guy TONER ◽

Adam BROAD ◽

Louise M CAMPANO ◽

Mark ROSENTHAL

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Hormone Refractory Prostate Cancer ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Hormone Refractory ◽

Macrophage Colony ◽

Stimulating Factor ◽

Download Full-text

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Line Treatment ◽

Hormone Refractory ◽

First Line Treatment

Download Full-text

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Cancer ◽

10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x ◽

1993 ◽

Vol 72 (6) ◽

pp. 1965-1968 ◽

Author(s):

Timothy M. Kuzel ◽

Martin S. Tallman ◽

Daniel Shevrin ◽

Edward Braud ◽

Lary Kilton ◽

...

Keyword(s):

Prostate Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Cancer Center ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory ◽

Download Full-text

Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)

Investigational New Drugs ◽

10.1023/b:drug.0000047109.76766.84 ◽

2005 ◽

Vol 23 (1) ◽

pp. 79-84 ◽

Author(s):

Tahir Latif ◽

Laura Wood ◽

Cindy Connell ◽

David C. Smith ◽

David Vaughn ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase II Study of Vinorelbine and Low-Dose Docetaxel in Chemotherapy-Naive Patients with Hormone-Refractory Prostate Cancer

The Cancer Journal ◽

10.1097/00130404-200307000-00011 ◽

2003 ◽

Vol 9 (4) ◽

pp. 286-292 ◽

Author(s):

Alan J. Koletsky ◽

Manuel L. Guerra ◽

Lori Kronish

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

Phase II study of vlnorelbine in patients with hormone refractory prostate cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)84523-6 ◽

1997 ◽

Vol 33 ◽

pp. S33

Author(s):

A. Caty ◽

S. Oudard ◽

Y. Humblet ◽

M. Beauduin ◽

E. Suc ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

899 PUBLICATION A phase II study of sequential chemotherapy with docetaxel-estramustine phosphate (DE) followed by mitoxantrone-prednisone (MP) in patients (pts.) with metastatic hormone refractory prostate cancer (MHRPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81194-2 ◽

2005 ◽

Vol 3 (2) ◽

pp. 258

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Estramustine Phosphate ◽

Sequential Chemotherapy ◽

Hormone Refractory

Download Full-text

Characterization of Prognostic Factors and Efficacy in a Phase-II Study with Docetaxel and Estramustine for Advanced Hormone Refractory Prostate Cancer

Oncology Research and Treatment ◽

10.1159/000088297 ◽

2005 ◽

Vol 28 (11) ◽

pp. 573-578 ◽

Author(s):

Thomas Nelius ◽

Frank Reiher ◽

Tobias Lindenmeir ◽

Tobias Klatte ◽

Olrik Rau ◽

...

Keyword(s):

Prostate Cancer ◽

Prognostic Factors ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text